# A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and Children

> **NCT05099029** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Enimmune Corporation** · enrollment: 3982 (estimated)

## Conditions studied

- Enterovirus Infections

## Interventions

- **BIOLOGICAL:** EV71 vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT05099029
- **Lead sponsor:** Enimmune Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-06-27
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 3982 (ESTIMATED)
- **Last updated:** 2024-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05099029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05099029, "A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05099029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*